We tested the in-vitro activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, trimethoprim-sulphamethoxazole, tetracycline, norfloxacin, ciprofloxacin, vancomycin, teicoplanin, clindamycin and five psychiatric drugs (chlorpromazirje, sertraline, fluoxetine, paroxetine and risperidone) against 32 strains of Corynebacterium urealyticum. Resistance rates exceeded 90% for all antibiotics except glycopeptides, quinolones and tetracycline. Sertraline was the most active psychiatric drug. We tested the influence of sertraline on the activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, trimethoprim-sulphamethoxazole, tetracycline and ciprofloxacin. We did not observe antagonism in any case. Sertraline enhanced the activity of ciprofloxacin and tetracycline against all strains (MIC decrease: 4-64-fold for ciprofloxacin, 2-32-fold for tetracycline).
Introduction
The importance of Corynebacterium urealyticum as a pathogenic microorganism has been undervalued for years. Its main pathogenic role was discovered in 1985, when it was described as the principal cause of encrusted cystitis (Soriano et al., 1985) . Since then, its pathogenic role in this form of cystitis, epidemiology and antimicrobial sensitivity have been studied extensively (Soriano & Fernandez-Roblas, 1988; Garcia-Rodriguez et al., 1991) , and it has been recognised in other types of infections (Vilaseca, Martinez & Angel, 1973) .
C. urealyticum is usually resistant to many antibiotics (Soriano & Fernandez-Roblas, 1988; Garcia-Rodriguez et al., 1991) . Frequently, it is resistant to most commonly used antibiotics, excepting glycopeptides, whose side-effects are well-known.
Some psychiatric drugs, such as chlorpromazine and derivatives and some monoamine reuptake inhibitors (MRI) have been shown to be active against microorganisms (Cederlund & Mardh, 1993; Kristiansen, 1992) , mainly Gram-positive bacteria. We have studied the in-vitro activity of five psychiatric drugs against C. urealyticum, and their influence on the activity of some antibiotics.
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Material and methods
Microorganisms
Thirty one strains of C. urealyticum, isolated from clinical samples, and C. urealyticum ATCC31456 were studied.
Antibiotics and psychiatric drugs
Eleven antibiotics (amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, clindamycin, trimethoprim-sulphamethoxazole, tetracycline, norfloxacin, ciprofloxacin, vancomycin and teicoplanin): one phenothiazine derivative (chlorpromazine), three selective serotonin reuptake inhibitors (SSRI) (sertraline, fluoxetine, paroxetine) and one serotonin antagonist neuroleptic (risperidone) were kindly provided, as standard powder, by their manufacturers.
Method
The in-vitro activity (MIC) of both antibiotics and non-antibiotic drugs was determined, by the agar dilution method, according to previously described methods (Garcia-Rodriguez et al., 1991) .
After assessing the activity of the drugs independently, we tested the influence of the most active psychiatric drug (sertraline) on the activity of selected antibiotics. We determined, by the same method, the in-vitro activity of amoxycillin, amoxycillin/ clavulanic acid, cefotaxime, gentamicin, tetracycline and ciprofloxacin, combined with sertraline at two-fold dilutions from 4 x MIC to 1/256 MIC for this compound for every strain.
Results and discussion
The MICs of the drugs tested are shown in Table I . Only vancomycin and teicoplanin were active against all the strains tested. All the strains were resistant to amoxycillin, and more than 90% of strains were resistant to cefotaxime and gentamicin. Fluorinated quinolones were active against 19.4%-32.3%, and tetracycline against 38.7%. All the psychiatric drugs tested showed activity against C. urealyticum. The most active non-antibiotic drug was sertraline, whose MICs for 50% of the strains and MICs for 90% of the strains were lower than those of all antibiotics tested except glycopeptides.
The results obtained for antibiotics combined with sertraline are shown in Table II . Antagonism was not observed in any case. Sertraline did not modify, at any concentration, the activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin and trimethoprim-sulphamethoxazole. Interaction with tetracycline but most notably ciprofloxacin was different. Sertraline, at concentrations of 1/32 MIC and lower, did not modify significantly the activity of tetracycline alone. At concentrations between 1/2 MIC and 1/16 MIC, it increased the activity of tetracycline against all the strains tested by two-fold to 32-fold (mode four-fold). In combination with ciprofloxacin, MICs of ciprofloxacin were four-fold to 64-fold lower than for the antibiotic alone for all the strains tested (mode four-fold). The increase of activity was the same for all concentrations of sertraline in the range tested (1/2 MIC-1/256 MIC). C. urealyticum-related UTIs are not common but are more frequent in patients with underlying predisposing factors, such as urological surgery or procedures and immunosuppression (Soriano et al., 1985) . Nevertheless, some workers (Nebreda-Mayoral, Mufioz-Bellido & Garcia-Rodriguez, 1994) have shown that C. urealyticum causes approximately one in every 25 microbiologically confirmed UTIs, and in some cases, previous broad-spectrum antibiotic treatment is the only predisposing factor. These infections may be difficult to manage because of their resistance to most antibiotics. They are usually resistant to /Mactams, aminoglycosides and trimethoprimsulphamethoxazole, and are frequently resistant to fluorinated quinolones (Soriano & Fernandez-Roblas, 1988; Garcia-Rodriguez et al., 1991) . Frequently, the only therapeutic options are glycopeptides.
Psychiatric drugs have been reported previously as active against both bacteria and protozoa (Cederlund & Marhd, 1993) . Tricyclic and heterocyclic antidepressants, neuroleptics and monoamine reuptake inhibitors are schizonticidal (Kristiansen, 1992) , and enhance the activity of chloroquine both against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum, even reversing chloroquine resistance in these microorganisms (Gerena et al., 1992) . They seem to act by inhibiting a chloroquine efflux pump structurally similar to the cell target sites in the brain (Coutaux, Mooney & Wirth, 1994) .
Among the psychiatric drugs tested, risperidone is virtually inactive, fluoxetine, chlorpromazine and paroxetine have activities similar to or slightly better than tetracycline; sertraline has the highest activity, better than that of all antibiotics tested except glycopeptides.
Obviously, these results should be evaluated in relation to pharmacokinetic profiles in assessing possible clinical usefulness. These SSRIs reach, at the usual recommended dosages, C^ around 0.1 mg/L, and less than 10% is eliminated unchanged in urine (DeVane, 1992) . Metabolic products of these drugs can be found in urine, but their antimicrobial activity is unknown. At usual dosages, it is unlikely that SSRIs influence the growth of microorganisms, since these concentrations are at least 100-fold lower than MICs of all the SSRIs tested against C. urealyticum. The differences between the CM, reached by these drugs and MICs for the most sensitive strains imply that a valuable subinhibitory effect is unlikely. The most feasible antimicrobial application of SSRIs is suggested by their antibiotic enhancing activity. Increased tetracycline activity is observed only at concentrations up to 1/32 MIC. More than 90% of strains are inhibited by this Cm». In contrast, the effect on the MICs of ciprofloxacin is the same at all concentrations of sertraline tested between 1/2 MIC and 1/256 MIC for every strain. Concentrations of sertraline following usual dosages can significantly modify the activity of ciprofloxacin against this microorganism, increasing its activity by up to 64-fold. For 47% of the resistant strains (MIC ;> 1 mg/L), such modification brings them within the sensitive (MIC <, 0.5 mg/L) range.
SSRIs act on the brain by inhibiting the reuptake of serotonin (5-OH tryptamine) by the presynaptic neuron. That seems to occur because they inhibit an energy-dependent pump, similar to those found in some protozoa, that cause drug efflux (Coutaux et al., 1994) . This may explain the reversibility of chloroquine resistance in protozoa. The mechanism of action of these drugs on bacteria is unknown. Moreover, the specific mechanisms by which C. urealyticum is resistant to most antibiotics is not well understood. /?-Lactamase production has not been described and as it is a Gram-positive organism, cell wall impermeability is unlikely. Thus efflux resistance mechanisms, that might be inhibited by these drugs, are possible. This should be confirmed by studying the influence of these drugs on antibiotic resistance in strains with known efflux pump-mediated antibiotic resistance, and studying drug concentrations within bacterial cells.
Some psychoactive drugs have intrinsic antimicrobial activity but their dosage and serum concentrations limit their clinical application in infection. They might be the basis for developing drugs with reduced psychiatric effects and improved antimicrobial activity. Efflux mechanisms are increasingly important in resistance to several antibiotics in a number of species. Whatever the target of these psychoactive drugs, the possibility of reversing resistance to drugs such as quinolones, in resistant bacteria suggests interesting possibilities for further study.
